[Form 4] Cushman & Wakefield plc Insider Trading Activity

Rhea-AI Filing Summary

Cushman & Wakefield plc (CWK) director Angela Sun sold 6,800 ordinary shares on 09/05/2025 at $16.02 per share, reducing her beneficial holdings to 46,498 shares. The filing is a routine Section 16 Form 4 disclosing an insider sale processed by an attorney-in-fact and signed on 09/09/2025. The record shows the transaction type as a direct disposition and provides the exact price and post-transaction holdings.

Positive

• Timely disclosure of insider sale with complete transaction details
• Proper Form 4 execution signed by attorney-in-fact, indicating procedural compliance

Negative

• Director reduced holdings by 6,800 shares, which may be viewed as insider liquidity
• No explanation provided in the filing for the reason behind the sale

Insights

Financial Analyst

TL;DR: Routine director sale; shows insider liquidity but no indication of material company change.

The Form 4 reports a direct sale of 6,800 shares at $16.02, leaving the reporting director with 46,498 shares. For investors this documents insider liquidity but does not include additional context such as reason for sale or relation to total outstanding shares. The transaction is clearly reported and timely filed by an attorney-in-fact.

Corporate Governance Expert

TL;DR: Compliance filing completed correctly; sale is a standard disclosure under Section 16.

The filing includes required details: reporter identity, relationship (director), transaction date, code (S), number of shares sold, sale price, and resulting ownership. The signature by an attorney-in-fact and the presence of transaction code indicate proper procedural handling. No governance violations or additional corporate actions are disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sun Angela

(Last) (First) (Middle)

225 WEST WACKER DRIVE

(Street)

CHICAGO IL 60606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cushman & Wakefield plc [ CWK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	09/05/2025		S		6,800	D	$16.02	46,498	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Noelle J. Perkins, attorney-in-fact	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Angela Sun report in the CWK Form 4?

The director reported a direct sale of 6,800 ordinary shares on 09/05/2025 at a price of $16.02, leaving 46,498 shares beneficially owned.

When was the Form 4 for CWK signed and filed?

The filing shows a signature by an attorney-in-fact on 09/09/2025 reflecting the reported transaction dated 09/05/2025.

What transaction code was used in the CWK Form 4?

The transaction is coded as "S", indicating a sale of securities.

Does the Form 4 explain why the sale occurred?

No. The filing does not include an explanation or stated reason for the sale.